Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill E Slansky

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|February 15, 2022
Granzymes: The Molecular Executors of Immune-Mediated CytotoxicityZachary L Z Hay, Jill E Slansky
Immunologic Research|September 15, 2012
Integrated immunology in ColoradoJill E Slansky, J John Cohen, John C Cambier
Journal of Clinical & Cellular Immunology|May 24, 2016
Tolerance of Tumor-Specific T cells in Melanoma MetastasesKatherine A Waugh, Sonia M Leach, Jill E Slansky
Vaccines|September 23, 2015
Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor ImmunityKatherine A Waugh, Sonia M Leach, Jill E Slansky
Current Protocols in Immunology|April 7, 2009
Vaccination of mice with baculovirus-infected insect cells expressing antigenic proteinsKimberly R Jordan, Fran Crawford, John W Kappler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2011
Elevated tumor-associated antigen expression suppresses variant peptide vaccine responsesCharles B Kemmler, Eric T Clambey, Ross M Kedl, et al.
Theranostics|May 7, 2020
A review of emerging physical transfection methods for CRISPR/Cas9-mediated gene editingApresio K Fajrial, Qing Qing He, Nurul I Wirusanti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
A modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor modelJennifer A McWilliams, Sean M McGurran, Steven W Dow, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigensKimberly R Jordan, Rachel H McMahan, Charles B Kemmler, et al.
Cancer Research|November 20, 2012
Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigensJonathan D Buhrman, Kimberly R Jordan, Lance U'ren, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|February 15, 2022
Granzymes: The Molecular Executors of Immune-Mediated CytotoxicityZachary L Z Hay, Jill E Slansky
Immunologic Research|September 15, 2012
Integrated immunology in ColoradoJill E Slansky, J John Cohen, John C Cambier
Journal of Clinical & Cellular Immunology|May 24, 2016
Tolerance of Tumor-Specific T cells in Melanoma MetastasesKatherine A Waugh, Sonia M Leach, Jill E Slansky
Vaccines|September 23, 2015
Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor ImmunityKatherine A Waugh, Sonia M Leach, Jill E Slansky
Current Protocols in Immunology|April 7, 2009
Vaccination of mice with baculovirus-infected insect cells expressing antigenic proteinsKimberly R Jordan, Fran Crawford, John W Kappler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2011
Elevated tumor-associated antigen expression suppresses variant peptide vaccine responsesCharles B Kemmler, Eric T Clambey, Ross M Kedl, et al.
Theranostics|May 7, 2020
A review of emerging physical transfection methods for CRISPR/Cas9-mediated gene editingApresio K Fajrial, Qing Qing He, Nurul I Wirusanti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
A modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor modelJennifer A McWilliams, Sean M McGurran, Steven W Dow, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigensKimberly R Jordan, Rachel H McMahan, Charles B Kemmler, et al.
Cancer Research|November 20, 2012
Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigensJonathan D Buhrman, Kimberly R Jordan, Lance U'ren, et al.
Pageof 6